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ABSTRACT 
 
 
 The use of stem cells to treat a wide range of injuries and degenerative diseases is 
currently one of the most exciting topics in the medical and scientific worlds.  The 
potential for success of this type of treatment seems extremely promising, however moral 
and ethical opposition has impeded the advancement of stem cell research.  This paper 
touches upon the various types of stem cells, their applications, as well as the ethical and 
legal issues surrounding this topic. 
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EXECUTIVE SUMMARY 
 
 
 Stem cells are at the forefront of regenerative medicine. Their capability to 
regenerate indefinitely and change into many different cell types shows good reason why 
stem cell research has grown so considerably in the past decade. This report discusses all 
aspects of stem cell research, from what they are and where they are found, to 
applications, ethics and national and state laws regulating their use.  Although the full 
potential of stem cells is great, they are actually quite delicate, and very difficult to derive 
and differentiate. 
 Chapter-1: The first chapter of this report discusses the main ideas behind what a 
stem cell is and where they are found in the human body.  Many types of stem cells exist. 
Adult stem cells are derived from tissues in an adult organism.  Such cells can be derived 
from the brain, bone marrow, liver and even in one’s eyes.  Adult stem cells are simply 
undifferentiated cells with renewal potential found inside some of our tissues.  These 
cells are used for specific tissue regeneration purposes when needed.   For example, if red 
blood cells are needed, hematopoietic stem cells are prepared from bone marrow or cord 
blood, and these cells will differentiate into all the cellular components of blood, 
including red blood cells, white blood cells, and platelets.  Human embryonic stem cells 
(hES cells) are similar to adult stem cells in that they have regenerative capacity, 
however they have the potential to differentiate into a large variety of tissues, thus the 
medical community is strongly interested in these cells.  ES cells are derived from the 
inner cell mass of a blastocyst, so unfortunately their isolation usually destroys an 
embryo, thus ES cells have strong ethical constraints on their use.  Currently less invasive 
methods of derivation are in trial phases. 
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 Much misinformation has occurred on exactly what can and can not be achieved 
using stem cells, so the purpose of  Chapter-2 was to document the various applications 
of different types of stem cells.  It is not true, as is often perceived, that no lives have 
been saved with stem cells.  Thousands of lives have been saved with bone marrow 
transplants over the past 30 years, while treating cancer patients undergoing radiation or 
chemotherapy.  Much information on stem cell use was originally obtained with animal 
research, and this knowledge is now being applied to humans.  Although adult stem cells 
were the initiating factor in stem cell research, the future rests in embryonic stem (ES) 
cell research.  Research has shown that ES cells may be capable of repairing and growing 
various types of tissues in the human body.  This could lead to the treatment of diseases 
that were once thought to be life ending.  ES cells may also be used to grow entire organs 
which could be used in organ transplants.  The process would allow the organ to be 
specifically engineered for a patient using nuclei isolated from their skin cells, thus 
eliminating the possibility of auto-immune rejection.  Scientists are also currently 
investigating the possibility of using ES cells as a delivery system for drugs and proteins, 
able to treat diseases in a manner that has never been done before.  The possibilities of ES 
cells seem endless, and further investigation will certainly lead to more promising 
applications. 
 Chapter-3:  The third chapter of this report explores ethical and moral issues 
concerning stem cells.  Adult stem cell therapies have been in practice for decades, and 
do not currently have much controversy.  All four major world religions support the use 
of adult stem cells to save lives.  However, ES cells are relatively new to the world, and 
have stirred up much debate and opposition.  Some are opposed to the further progression 
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of ES cell research because not enough is currently know about the effects of putting 
such cells into humans, side effects and mutations may be inevitable.  The four major 
religions of the world all have their own unique view on stem cells applications, but three 
are not fully against the idea because they know that lives will be saved and humankind 
will benefit from ES treatments.  As compared to the rest of the world, the United States 
appears to have the most closed minded view on stem cell research.  Countries 
throughout Europe and Asia are far more willing to further explore the idea of ES cell 
therapies.  
 Chapter 4 discusses various laws regulating stem cell uses.  On a world scale the 
United States falls into a moderate category when discussing stem cell legislation. The 
Clinton Administration started the push for advancements in stem cell legislation by 
asking the National Bioethics Advisory Commission (NBAC) to write a report on stem 
cell research in the U.S.  Near the end of his second term in office, the report was 
finished and viewed by both Pres. Clinton and Bush.  This report proposed 13 guidelines 
that established what was acceptable for federally funded researchers.  Unlike some 
countries ES cell research is legal in the U.S., although it is not currently fundable with 
federal money.  The U.S. also differs from the rest of the world when it comes to 
legislation because not only does the U.S. have a national policy, state governments are 
also allowed to make their own rules regarding ES research. Currently some states have 
floated bonds to pay for stem cell research, California was the first, followed by New 
Jersey and Massachusetts.  While the U.S. has a moderate policy in place, many scientists 
argue the lack of federal funds will eventually choke U.S. research, and other coutrires 
will eventually surpass us in this area.  The national government needs to coordinate with 
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local governments to organize a more nationally accepted policy, laws that would 
hopefully allow the U.S. to remain one of the top stem cell and bioscience researching 
countries.   
 In conclusion, this report covers the science of stem cell research and its impact 
on society.  Subjects that were discussed are as direct as what a stem cell is and where 
they are found, but also as complex as their applications, the ethics behind using them, 
and the laws that govern researchers.  The authors of this IQP agrue that the advancement 
of stem cell technology is something the U.S. should strongly support.  The potential that 
these cells have in regenerative medicine is possibly the most important biological 
discovery in this century.  
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PROJECT OBJECTIVE 
 
 
 The purpose of this project was to investigate the new technology of stem cells, 
and describe their impact on society.  The objective of chapter-1 was to discuss the 
various types of stem cells and where each one is found.  Chapter-2’s objective was to 
demonstrate the different applications for each stem cell type.  The ethical and moral 
issues surrounding this topic are presented in chapter-3.  The goal of chapter-4 was to 
document the different laws regarding stem cell use.  The final section contains the 
author’s conclusions on this controversial subject. 
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CHAPTER-1:  STEM CELL TYPES AND LOCATIONS 
 
What is a stem cell?  Stem cells are immortal cells that have the ability to self 
renew, and to change into other types of cells.   All mammalian organisms have stem 
cells, from mice to humans. The environment in which the cell is grown and nurtured will 
dictate what type of stem cell it is.   These environments created a huge range of stem 
cells, some more complicated than others, and some more useful. The two main groups of 
stem cells are adult stem cells (AS cells) that are obtained from an adult, and embryonic 
stem cells (ES cells) that are obtained from day-5 embryos.   
  Figure 1: hES cell culture dishes 
 
 One of the special qualities of stem cells is their ability regenerate itself for 
extended periods of time; this process is known as proliferation. This feature is unique to 
these cells because as proliferation continues, if cultured correctly, millions of cells will 
be made that carry no specific purpose or task. This characteristic also allows stem cells 
to be able to remain in certain tissues until they are need for more specific purposes.  If 
cultured properly in labs, stem cells can proliferate and stay unspecialized almost 
indefinitely. 
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The second feature of stem cells is their ability to differentiate into other types of 
cells, or cells with a more specialized function.  For example, bone marrow 
hematopoietic stem cells (HSCs) have the capacity to create blood cells (red and white) 
and platelets.  Differentiation is the process a stem cell will undergo as it changes from an 
unspecialized cell into a cell that is going to be used a specific purpose.  The ability for 
stem cells to differentiate is the reason medical researchers are so interested in them.  
Such cells form the basis of the new field of regenerative medicine. 
 
Adult Stem Cells 
 AS cells are stem cells found in specific tissues within adult mammals.  
Scioentists are still debating which adult tissues contain them, and whether such cells 
have the capacity to save lives, but their use does not destroy an embryo.  One drawback 
however is they can only differentiate into one tissue type, usually the one they were 
isolated from. 
  
   
Figure 2: Demonstration of the regenerative ability of AS cells. 
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Figure 2 illustrates progress that is being made in this area, adult bone marrow stem cells 
are being differentiated in various environments into cell types that will aid in getting the 
tissues back to a healthy status.    
 Unlike stem cells, regular cells within our body are used to their fullest and then 
disposed.  When these cells die off, new ones are sometimes created to take their place. 
This is why AS cells are so important to our well being. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Figure 3: Differentiated pulmonary stem cells. 
 
As an example of adult stem cells, the best characterized are the hemopoietic stem 
cells (HSCs).  Everyday 300 billion HSCs are differentiated into platelets, and red and 
white blood cells.  The human body also contains more specific adult stem cells, such as 
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bronchial or alveolar stem cells.  In Figure 3, specific destinations are shown for the new 
cells created by differentiated mesoderm stem cells. These tissues are necessary for the 
function of the lungs.   Other major adult stem cells include: endothelial stem cells, 
epidermal stem cells, gastrointestinal stem cells, liver stem cells, kidney or renal stem 
cells, lung or pulmonary stem cells, neural crest stem cells, neuronal stem cells, 
pancreatic stem cells, prostate stem cells and retinal stem cells.  These AS cells and many 
others keep humans breathing, seeing and walking.  Possibly in the future stem cells will 
allow diseased people to do these things again. 
 
Embryonic Stem Cells 
 ES cells are the main basis for regenerative medicine.  ES applications are being 
found to cure simple colds or something as complex as Alzheimer’s Disease.  As stated 
previously, ES cells have very much in common with AS cells, such as their ability to 
proliferate indefinitely in an undifferentiated state, but they can differentiate into a 
variety of tissues.  ES cells are obtained from in vitro fertilized eggs grown for about 5 
days to the blastocyst stage (see Figure-5).  This “hollow microscopic ball of cells” is 
made up of three main parts. The outermost layer is the trophoblast, mainly a protective 
and sensory layer for the organism. Inside this layer is a fluid filled cavity called the 
blastocoele. Within this blastocoele lies the most important part, the inner cell mass. The 
inner cells mass is comparable to a yolk of an egg. At this stage, the ES cells constitute 
the inner cell mass.  Their isolation destroys the embryo.  The extracted ES cells are put 
into a new environment in order to proliferate, and eventually be differentiated.  Figure 4 
shows one form of external culture environment, a mictotiter culture dish. 
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Figure 4: Culture dish being examined for irregularities in 
stem cell growth. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Figure 5:  Diagram of a blastocyst and its various tissues. 
 
 ES cells if cultured correctly have to ability to take on the structure and purpose 
of any other cell in the human body.  After proper culturing and proliferation, thirty ES 
cells could yield millions of cells.  
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 The culturing process is not easy.  Scientists and researchers spent twenty years 
struggling to grow ES cells in lab cultures. The process all starts with the extraction of 
the stem cells from the ICM, inner cell mass. Once the cells are gathered, they are placed 
into cultures with a specific culture medium or fluid.  The culture dishes are also lined 
with what is called a feeder layer.  This layer, usually mouse fibroblast cells (and more 
recently human fibroblast cells), is used to provide growth factors and attachment sites,  
much like the lining of a uterus.  As cultures fill with new cells, they are separated into 
numerous different dishes and allowed to continue proliferating. When enough cells have 
been made, they are then differentiated into certain cell types controlled by the scientists 
working with the cells. 
 
          
Figure 6:  20x view of human ES 
cells.  hES cell are the dense clusters 
located in the center of the figure.  
The long skinny cells are the “feeder 
layer”. 
 
 
 
 
 
 
 hES cells are also important to research because they allow information to be 
gathered about early cell development.  Unfortunately this type of cell is falling far 
behind in the race of regenerative medicine, due to ethical and moral issues surrounding 
their use.  These will be discussed in chapter-3. 
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CHAPTER TWO:  STEM CELL APPLICATIONS 
 
 Stem cells are the key to opening a new door for regenerative medicine.  Because 
the public often argues that stem cell research is “pie in the sky” and has yet to save any 
lives, the purpose of this chapter is to document the kinds of experiments that have 
already been successfully performed with stem cells. 
 Therapies using adult stem cells have been in use for over forty years, 
successfully treating patients with various types of autoimmune diseases (University of 
Minnesota, 2005).  Although the use of embryonic stem (ES) cell therapy on humans is 
not yet permitted throughout most of the world, animal studies have proven that these 
types of cells will advance the medical world significantly.  Many incurable diseases and 
permanent injuries could be treated with stem cell therapies, and further investigation of 
these cells may allow the mechanisms of tissue development and specialization to be 
mastered by scientists and engineers worldwide (National Research Council, 2003). 
 
Adult Stem Cell Treatments 
 The first successful human stem cell therapy occurred in 1968, wherein adult 
bone marrow stem cells were transplanted from a donor.  The bone marrow of an infant 
boy had been destroyed by radiation and chemotherapy while undergoing therapies to 
treat his sickle-cell anemia.  The allogeneic (tissue matched) transplant allowed the 
donated adult hematopoietic stem cells (HSCs) to regenerate the boy’s blood and to allow 
his immune system to once again function properly.  Umbilical cord blood also contains 
adult HSCs that can be used to treat autoimmune diseases (Viacell, 2005).  Because these 
cord HSCs are obtained from “younger tissue”, they display less graft-versus-host disease 
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than bone marrow HSCs.  Stem cells are labeled “adult” when they are harvested from a 
human after birth, so cord HSCs are actually considered “adult” to distinguish them from 
ES cells.    Umbilical cord blood transplants are the preferred method of treatment 
because this process posses less of a risk and has a higher success rate.  Despite the 
method chosen, once the donated adult stem cells have been placed into the patient, the 
cells immediately go to work, replenishing the patient’s blood and immune system.  A 
simple blood transfusion could provide temporary relief to certain patients, but stem cells 
harvested from umbilical cord blood settle deep into the patient’s bone marrow, 
producing all the components of blood for the entire life of the patient.  Both umbilical 
cord blood and bone marrow stem cells have been used to effectively treat various types 
of cancer.  Clinical studies have involved patients with Non-Hodgkin’s Lymphoma, 
Pancreatic, and Ovarian cancers.  After each study most patients have improved 
conditions and reduced symptoms.  Figure-1 below illustrates the proteins provided by an 
immune system after adult stem cell therapy.  The patient’s immune system would have 
produced very little to none of the disease fighting proteins before the therapy (Weiss, 
2005). 
 
  Figure 1:  Red Blood cell shown with disease fighting antibodies, provided by the  
  hematopoietic stem cell transfusion.  Image provided by www.allrefer.com. 
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Adult Stem Cells harvested from the patients own body can also be used to battle 
certain autoimmune diseases.  If the patient is suffering from a disease that does not 
affect their bone marrow, healthy stem cells will be used as treatment and an autologous 
(same patient) transplant will occur.  In some trial cases, Lupus patients would have stem 
cells harvested from their own healthy bone marrow and injected into locations affected 
by the disease.  The result of this therapy was the healing of what other doctors had called 
“irreversible damage”.  Seventy-five percent of the patients treated in this study 
experienced remission from the disease for two to three years (Weiss, 2005). 
At an Italian eye bank, stem cells were harvested from a patient’s healthy eye, and 
injected into the other damaged eye.  The adult stem cells were taken from a part of the 
cornea called the limbus.  The cells were then used to form a transparent membrane over 
the damaged portion of the unhealthy eye.  The arrow in Figure-2 indicates the damaged 
portion of the cornea, which was treated with this procedure. A tear or a burn may have 
caused the damaged corneal tissue.  The stem cell-formed membrane produces fresh and 
healthy tissue.  The most unique aspect of this therapy is that the stem cells actually 
located the damaged portion of the cornea and were furtively instructed to perfectly 
repair the eye.  This form of treatment is far more effective than any other known cornea 
related procedure, but little documentation has been made about why the cells behave in 
the manor that they do (Holland, 2005). 
 
 Figure 2:  A damaged cornea to be treated using the patients own 
 stem cells.  The hazy portion of the cornea represents the 
 unhealthy tissue.  This image provided by www.schultze-eye.com. 
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The therapies that utilize adult stem cells are relatively new but with further 
research and testing, these types of cells may have more abilities than previously thought.  
In one clinical trial stem cells harvested from bone marrow were used to treat patients 
who had recently experienced a heart attack or heart failure.  The stem cells were injected 
into the arteries of the heart, and the patients’ cardiac functions and health was reported 
to have improved dramatically.  Scientists are not sure if the stem cells formed new 
cardiac cells, but they most certainly are promoting healing and new growth.   
Individuals with rheumatoid arthritis have also participated in trials with adult 
stem cells.  The cells were used to jump start the repair of the eroded tissue between 
joints.  Patients treated claimed that the pain from the arthritis had become dramatically 
less severe and stated “the relief was better than any drug ever taken” (Hall, 2005).  
Figure-3 below illustrated the damaged cartilage of a rheumatoid patient; adult stem cell 
therapy may provide just enough cartilage growth for a significant amount of pain 
reduction (Hall, 2005). 
 
Figure 3:  A knee damaged by rheumatoid arthritis will be treated with adult stem cell therapy, 
providing pain relief and aiding in tissue growth.  Image provided by www.health.allrefer.com. 
 
  
 Adult stem cells taken from the bone marrow of healthy donors have provided an 
enormous amount of information about the multipotency of adult stem cells.  In various 
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labs all over the world, these types of stem cells have been manipulated to grow several 
different types of cells and tissues; including the three major types of brain cells 
(neurons, glia, astrocytes).  This could lead to newer and more refined therapies used to 
treat Alzheimer’s and other brain degenerative diseases.  Stem cells harvested from the 
human brain have also been found to produce blood and muscle cells.  Adult stem cells 
are wonderfully useful in medicine and scientific research, but they are incredibly hard to 
obtain. Research thus far has shown that adult stem cells are limited as to how far they 
can go in terms of regenerative medicine.  While stem cells have been used to treat 
cancer patients and others with autoimmune diseases, it is extremely difficult to pair up 
some patients with a donor carrying the correct histocompatible antigens.  Isolating an 
adult stem cell in the human body is not only a lengthy process, but also an 
extraordinarily expensive one.  Figure-4 below illustrates a stem cell found in the bone 
marrow of a human.  Searching for these cells is quite literally like looking for a needle in 
a haystack (National Research Council, 2003). 
 
Figure 4:  A microscopic stem cell rests within a vast jungle of bone marrow.  The isolation and 
removal of these types of cells is a tedious and arduous procedure.  Image provided by 
www.stanfordalumni.org. 
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Embryonic Stem Cell Therapies 
 
 Although adult stem cells were the initiating factor in stem cell research, the 
future rests in embryonic stem (ES) cells.  This form of therapy is not yet legal in the 
United States for human testing, but extensive lab work and animal investigation has 
given researchers much optimism.  Embryonic stem cells are easier to harvest directly 
and if eventually legalized, regenerative medicine will change the world.   
 One major difference between ES and adult stem cells is that adult stem cells are 
very useful for therapeutic replacement of damaged or diseased cells, but they cannot 
grow and replace complete damaged organs.  In the laboratory ES cells have been 
manipulated to grow various types of tissues, and for the most part the cells have always 
been self-renewing (National Research Council, 2003).  For example, when scientists 
transplanted neuronal ES cells into the damaged brain of a mouse, the stem cells not only 
survived but also worked along side the existing neurons of the mouse’s brain.  The cells 
then worked with the existing neuronal tissue to repair lesions and promote re-growth of 
damaged cells.  Stem cells injected into the brain of mice have successfully located and 
repaired damaged tissue in several trials.  Scientists believe that this process may also 
prevent neurodegenerative disease as well as promote healing.  This application in 
humans could be incredibly useful in treating various illnesses such as Parkinson’s and 
Alzheimer’s disease, brain damage, genetic disorders, and possibly even spinal cord 
injuries.  Figure-5 below shows a senile plaque formed on a brain from the toxic protein 
amyloid in Alzheimer’s patients.  Treatment with neuronal cell transplants could possibly 
repair the plaques and tangles associated with this degenerative disease, slowing the 
progression of the illness (Weiss, 2005). 
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 Embryonic stem cells have also experienced much success in animal studies with 
treating degenerative muscular disease.  Individuals suffering from Duchene Muscular 
Dystrophy may someday undergo a therapy in which embryonic stem cells are used to 
grow and replace the muscle that has been deteriorated by the disease.  When mice with 
Duchene’s were treated with the stem cells, the muscle growth that occurred was 
miraculous.  The mice not only grew back the muscle they had lost because of the 
disease, but they continued to grow becoming larger and more muscular than even the 
healthy mice.  Figure-6 below shows a before and after scan of the leg of a mouse treated 
with this therapy, the green represents new muscle growth.  This treatment was also 
performed on dogs with muscular dystrophy, and again the dogs grew larger and stronger 
than normal animals.  This provided enough information for scientists and engineers to 
conclude that the stem cells promoted growth in the animals’ own muscles, forming new 
tissue and building up the old host fibers (Potten, 1997). 
Figure 5:  A brain damaged by Alzheimer's shows various lesions caused by a toxic protein.  Neuronal 
stem cell treatment could repair damaged areas and prevent further progression of the disease.  Image 
provided by (Brain…1999).   
 22 
 
Figure 6:  The image on the left is a scan of new muscle growth in the leg of a mouse before stem cell 
therapy.  The image on the left clearly illustrates the large amount of new muscle growth after the 
embryonic stem cells were introduced to the host fibers.  Image provided by (Researchers Reveal, 
2005). 
 
 Spinal cord injuries are among the most life changing and emotionally devastating 
injuries, leading to paralysis and a dramatic change in lifestyle.  Extensive research has 
been conducted concerning stem cells and the spine.  Laboratory mice were manipulated 
such that their spine was carefully severed leaving the mouse paralyzed in the rear legs 
and tail.  Scientists then created a specialized formula from an embryonic stem cell.  
After the mouse was injected with the therapy, the scientist could not believe the results.  
The spine and nerves which had been severed had re-grown, and the mouse was now able 
to walk with it’s rear legs and movement was visible in the tail.  The recovery was not 
full, a slight shuffle was present, but the ability to travel was regained.    Several other 
studies have been completed all with promising results.  Further research and a change of 
policies could lead to paralysis becoming an issue of the past (Weiss, 2005). 
 Organ transplants are another area in which ES cell research has been applied.  
The process of matching a donor with a patient is often difficult, and patients may wait 
months or years to find the correct match.  Even after a match has been made and the 
transplant completed, the road to recovery is not an easy one.  The recipient will need to 
take immune suppressive drugs so that their body does not reject the new organ.  These 
drugs are often incredibly harsh on the body and sometimes cause sickness and anxiety 
that is unbearable.  Prior to stem cell therapies, scientists were investing a process where 
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a biopsy was taken from the unhealthy organ.  The cells removed from the organ were 
then grown and fed on a collagen scaffold.  The hope was that the cells would form into a 
new and healthy organ; but limited success occurred.  The grown organs are not useful to 
the human body due to the fact that the body will not absorb tissue that does not contain 
blood vessels.  Another set back to this procedure is that the faulty organ is often so 
damaged that there is not enough healthy tissue to take a biopsy from.  Embryonic stem 
cells could completely change this, allowing for perfectly functional organs to be created 
that are an exact histological match to specific patients.  The need for immune 
suppressing drugs would no longer exist, and virtually every person needing an organ of 
some nature would be fulfilled.  In a California laboratory, ES cells have been 
manipulated under very specific conditions to form masses of heart muscle that beat in 
perfect unison (Hall, 2005).  Further improvement upon this research could lead to the 
development of specialized organs and tissues, used as transplants or as treatment to other 
degenerative diseases.  Figure-7 shows two different types of tissues successfully grown 
in the laboratory from stem cells.    
 
 
Figure 7:  The image above is a photograph of tissues grown using embryonic stem cells.  The image 
on the left is of epithelial cells, and the image on the right shows neuronal cells.  Figure provided by 
www.itb.cnr. 
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Stem Cells as Delivery Systems 
Stem cells manipulated by scientists not only grow various types of tissues but 
also act as drug and therapeutic protein carriers and producers.  In turn, this means that 
stem cell therapy could be used to treat degenerative disease as well as viruses and other 
infectious agents.  Muscle stem cells have been engineered to successfully carry and 
deliver Human Growth Hormone to mice in the laboratory.  This system is possible 
because once the stem cell is injected into the host muscle it has direct access to vascular 
circulation.  The multipotency of stem cells is quite apparent once again, now not only 
can muscle stem cells be used to treat degenerative disease but they can also be used as a 
drug delivery system (Potten, 1997).  Muscle stem cells are not alone in this category; 
engineers strongly believe that neuronal stem cells could also be manipulated in this 
manor.  More specifically they are currently working on using embryonic fetal tissue, 
along with a patient’s on neuronal stem cells to treat patients with Parkinson’s disease.  
The hope is that if the stem cells are matured properly they may be able to form the 
dopamine producing cells that are destroyed by this disease.  Various attempts have been 
made to produce this type of cell, but the success rate thus far has been fairly low (Weiss, 
2005). 
Similar studies are currently underway to use embryonic stem cells as a treatment 
for Type I Diabetes.  The medical world has been working on discovering a way to create 
the insulin-producing cells that are destroyed by the patients’ own immune system.  
Scientists are currently working on “training” stem cells to mimic the behavior of the 
pancreatic islet cells that produce insulin, which without a doubt would have a profound 
affect on the disease.  Recent developments using specialized proteins to spur cell 
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differentiation are believed to aid in making this therapy a reality (Holland, 2005).  A 
group of American scientists working in Britain were able to use a concoction of 
chemicals to convert a brain stem cell into the insulin producing islet cells.  When 
injected into a mouse and tested four weeks later, the brain stem cell was still alive and 
the insulin production of the mouse had increased drastically (Brain Stem Cells…2005). 
Just last year in Spain, scientists completely reversed the symptoms of diabetes in a sick 
mouse utilizing embryonic stem cells.  They used a process that manipulated the DNA of 
the insulin gene and then inserted that into an embryonic mouse stem cell.  The hybrid 
stem cell was then cloned and injected into the mouse, curing it of diabetes.  Figure-8 
illustrates the steps that the scientists took and also provides a graphical representation of 
the change insulin production (Cancer Facts…2004).   
 
Figure 8:  Careful manipulation of the insulin gene and embryonic stem cells allowed Spanish 
scientists to cure a mouse of diabetes.  Above are the major steps they took and a graphical 
representation of insulin production.  Image provided by (Stem Cells and Diabetes, 2005).   
  
 Stem cells of all types are useful as therapeutic treatments, but also can be studied 
and tested to provide information furthering the medical world.  Stem cells could revile 
the unknown regenerative properties of the liver and skin tissue, and also provide further 
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information into the process of cell differentiation (National Research Council, 2003).  
Permanent injuries and untreatable diseases have been reversed in laboratories all over 
the world using stem cell therapies.  Millions could be treated suffering from a wide 
range of medical issues, anything from Parkinson’s disease to severe burns.  Specific 
lines of stem cells harboring certain abnormalities would allow testing and therapies to 
unveil new methods of treating those suffering from disease and sickness.  Further 
investigation into adult stem cells may lead to the discovery of new cells readily available 
in the human body, without destroying an embryo to obtain them.  The birth of the a new 
age in medicine and science using stem cells has just barely began, and certainly the 
world will benefit dramatically from this new kind of therapy.      
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CHAPTER-3:  STEM CELL ETHICS 
 
 The scientific and medical worlds have always sparked controversy and given rise 
to ethical questioning.  New developments and cutting edge technologies are usually the 
targets of social unrest, usually because the general public is fearful of what it not well 
understood and widely accepted as the “norm”.  Today it is hard to pick up a medical 
journal and not find research or information relating to the topic of stem cells.  Adult 
stem cell therapies have been in use for years, but the focus on the potential of embryonic 
stem (ES) cells has caused much incongruity.  Political and social views on the this topic 
have significantly impeded the progression of ES cell applications, particularly in the 
United States; while other locations throughout the world are quickly gaining momentum 
in the world of regenerative medicine. 
 The use of adult stem cells to treat patients suffering from a wide range of 
illnesses has been in practice for decades.  Initially, as with all pioneering medical 
applications, ethical issues were raised as to how safe these processes and procedures 
actually were.   Initial success in the laboratory using animals is now being followed by 
human clinical trials.  This highly documented and regulated progression brought ease to 
most of the ethical and moral qualms surrounding adult stem cells.  In current times, 
procedures such as bone marrow transplants, are a common everyday practice; it is 
understood that therapies such as these save lives while not destroying an embryo to 
obtain the stem cells.  In fact, all four of the world’s main religions support the use of 
adult stem cells for improving the common good.  However, adult stem cells have fewer 
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regenerative capacities than ES cells, and all eyes are on the applications of embryonic 
stem cells.    
ESC research is highly controversial, raising both moral and ethical opposition.  
Most of this unrest is due to the fact that an embryo about day-5 of creation is destroyed 
in order to harvest ESCs.  This opposition has severely slowed further advancement on 
research that is needed to fully understand the applications of these mysterious cells; cells 
that could lead to the curing of many degenerative diseases, and possibly even tissue or 
full organ growth and replacement.  Figure-1 is a photograph of an embryonic stem cell, 
the topic of much debate (National Research Council, 2003). 
 
Figure 7:  The photograph above shows an embryonic stem cell, this microscopic cell causes much 
controversy and ethical questioning. Image provided by www.allhatnocattle.com. 
 
 
Opposition from Scientists and Engineers 
The most feasible and well supported argument against ESC applications has 
come from the scientific and medical worlds.  ESC research is groundbreaking and 
therefore has many loopholes that have people questioning the safety and morality behind 
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their use.  The most serious concern of stem cell applications comes from the possibility 
that all ES cell lines eventually will change and mutate into potentially harmful ones.  
The technology of inducing immortalized cell lines has long been accepted as common 
practice, but these cell lines are not used for organ replacements in which mutations 
could have serious consequences.  Scientists fear that if large banks of stem cells are used 
in therapeutic applications, mutations and abnormalities could lead to unwanted and 
dangerous side affects.  For example, if a stem cell is harvested from an individual who is 
the carrier of a genetic disease, each cell derived from that stem cell would also carry the 
harmful mutation (National Research Council, 2003).  However it has yet to be seen 
whether ES cell lines spontaneously mutate when taken from healthy volunteers. 
 The multipotency of stem cells has also raised much concern over their 
applications.  Even with much research and clinical trials, scientists have not been able to 
fully control the ability of stem cells to form into many different types of tissues.  The 
best example of this occurred in the laboratory on a mouse.  A human ESC was injected 
into the mouse, and this caused the formation of various types of growths such as fatty 
tissue, hair, teeth, and lung tissue.  This result was promising in that various types of 
tissues formed from one cell, but on the other hand the results were unpredictable and 
dangerous.  These results in human applications could result in cancerous growths and 
may lead to sickness or even death; which quite obviously has raised many ethical and 
moral issues.  There is also a concern with the actual injection of the stem cells into a 
patient; the wrong location could lead to a failed procedure or horrifying side effects.  
Figure-2 is a photograph of a generation of mice that have been treated with the highly 
controversial embryonic stem cells (Potten, 1997). 
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Figure 8:  The photograph above is of a family of mice all used in experimental embryonic stem cell 
research.  Though these mice appear to be physical healthy, not all applications have turned out 
successful.  Image provided by www.utmb.edu. 
  
 
 Another issue that has raised great concern among researchers is the fact that stem 
cells are currently cultured in a non-human serum (usually fetal bovine serum with a 
feeder layer of mouse cells).  This has led to a fear of a potential health risks and the 
spread of non-human disease to individuals treated with stem cells.  The feeder cells used 
in the culturing phase are usually obtained from mice or cows (National Research 
Council, 2003).   In the case that stem cell therapies are legalized in the United States, a 
human based or synthetic serum would have to be utilized, ensuring the public that there 
is no chance of rodent or bovine disease crossing over to humans.  Geron, a stem cell 
research company based out of California, has made claims that they have created such a 
serum; possibly deleting one concern on this highly debatable topic.  In addition, several 
labs have recently learned how to culture ES cells without the feeder layer cells 
(International Stem Cell Meeting, San Francisco, Summer 2005), so these new ES cell 
lines would not be contaminated by animal products.  But to use these new ES cell lines 
in federally funded research would necessitate a reversal of the Bush 2001 legislation 
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banning the generation of new ES lines.  Figure-3 shows adult neuronal stem cells which 
were cultured in a rodent derived serum (Weiss, 2005). 
 
Figure 9:  The image above displays adult neuronal stem cells successfully cultured in a rodent 
derived serum.  Image provided by www.neuronnova.com. 
 
  
The applications of stem cells to regenerative medicine would largely encompass 
the insertions of new tissue into a patient with damaged or diseased organs.  Stem cell 
derived tissues have been grown effectively in the laboratory, but there has been no such 
case where the tissue was proven to be fully functional and normal.  Until the 
implementation of human clinical trials, there will be no way to guarantee that the grown 
tissue will survive in the human body.  Though many researches believe that these 
processes will be very successful because the tissue is stem cell derived, and can be 
matched easily with a patient; there is still an underlying fear of immune-mediated 
rejection.  This has raised ethical issues over whether or not it would be worth it to spend 
the time and money on a procedure that may fail.  There is a possibility that the patient 
may have to spend the rest of their life ingesting immunosuppressive drugs, which are 
often life threatening and bring new side effects (National Research Council, 2003). 
 Stem cell research is not the first scientific and medical topic to raise great ethical 
opposition.  When DNA recombinant techniques initially came into the public eye, 
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opposition of all sorts came from social groups throughout the world.  These issues were 
eventually resolved when committees were developed to set guidelines and standards 
which ensured that the research was conducted to the highest of medical and ethical 
standards.  If the United States government chooses to fund stem cell research, similar 
assemblies could be formed to monitor and regulate the procedures.  This would allow 
research to progress and for the true practicality of stem cells to be understood (McClean, 
1997). 
 
Religious Views on Stem Cells 
 Ethical opposition from various religious groups has caused a major setback for 
stem cell research, especially related to ES cell harvesting.  Surprisingly, the views of 
different religious groups vary significantly; and even the thoughts of individuals within 
the same religion can show a drastic discrepancy.   
 The roots of most of the debates come from the fact that when harvesting an ESC, 
a human embryo is destroyed.  ES cells are derived from the inner cell mass of the 
blastocyst at day-5 post-fertilization.  The blastocyst is about the size of the period at the 
end of this sentence, and has no brain, eyes, nerves, etc.  There has been much argument 
as to when life actually starts for an embryo, and the various religions all have a different 
view on it.  The Jewish people believe that an embryo has no moral status until 40 days 
after conception.  They also believe that the life of embryo does no begin until after the 
birth of the baby, before that the embryo is just a part of the mother’s body.  The Jewish 
faith has stated that if the embryo was conceived outside of the body (in vitro), the 
embryo is of no moral or legal status; sperm and egg mixed outside of the body is not a 
conception.  Thus, while it seems that the Jewish faith is not strongly opposed to ES cell 
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research, they have made it public that they feel ESC harvesting denies the embryo a 
future to evolve into a life, so some are against ESC research (Eisenberg, 2001).  
However others in the Jewish faith see no problem with it so long as it supports the 
common good (saves lives). 
 The Muslim’s view on when life begins is similar to the Jewish people in that 
they do not believe life begins immediately upon conception; Muslim law sates that life 
begins for the embryo four months into the pregnancy, which is well after blastocyst 
formation.  As for specific laws applying to stem cells and abortions, the Muslim faith 
does not have a central authority to state a specific position.  Generally, Muslims are very 
conservative and deeply religious, yet most are not opposed to stem cell research because 
they do not believe that the embryo possesses a soul until the later stages of the 
pregnancy.  Of course there are Muslims who are deeply against ESC research because of 
the destruction of an early embryo.  As with all of the religious groups, Muslims seem to 
be split as to what shall be allowed in stem cell research.  Figure-4 is of photographs 
taken at a stem cell research laboratory located in Cairo, Egypt (Dabu, 2005). 
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Figure 10:  The images above were taken at a stem cell research laboratory located in Egypt.  
Facilities of this nature are new to this area which is heavily populated by Muslims.  Image provided 
by www.cbsnews.com. 
 
 The scientist that first successfully cloned the world’s first stem cell line in 2003, 
was a professor by the name of Hwang Woo-suk.  Professor Woo-suk is a practicing 
Buddhist, and gives his faith the credit for his success.  Woo-suk says that in every aspect 
of his research he makes sure it follows in the spirit of Buddha.  If he ever had a doubt 
about the ethics behind his research, he would cease immediately.  Woo-suk claims that 
the compassion of the Buddhist faith, and it’s long history of practicing medicine to 
alleviate suffering has allowed the Buddhist people to embrace stem cell research and 
biotechnology as a whole.  The Buddhist do not view an early-embryo as life, the embryo 
must be inside of a uterus for life to begin (Tae-gyu, 2005).  Though the Buddhist faith is 
seemingly open to the idea and practice of stem cell research, there are still practicing 
Buddhists that do not approve of ESC research because of the deliberate destruction of 
life (Buddhism and Stem Cells…2005). 
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Professor Woo-suk not only admitted that his faith allows him to carry out research with 
stem cells, but he knows that if he were a Roman Catholic, he would have never been 
allowed to do what he has done (Tae-gyu, 2005).    
 The Roman Catholic Church has extremely strong moral and ethical qualms with 
ESC research.  The Pope, the head of the Church, publicly denounces all forms of ESC 
research and claims that it is the same as abortion; a crime.  The Vatican has even been so 
bold as to claim that scientists and researchers are committing murderous acts when 
conducting ECS research (Weiss, 2005).  In the past Catholics used to follow the same 
views as the Jewish people, that an embryo is not considered “living” until 40 days after 
conception.  In 1869, the church adopted the idea that human life begins at the time of 
conception, because there is no way to positively determine when life actually begins.  
Therefore, the Catholic faith is completely against any type of research in which an 
embryo is destroyed (National Research Council, 2003).  Their defense is that the only 
difference between an embryo and a baby is time, and both deserve equal protection.  Not 
all Roman Catholics believe that ESC research is as erroneous as the church is claiming, 
and feel that the research must go on in order to fully comprehend how stem cells could 
benefit the world.  Christians as a whole are generally not in support of ESC research, but 
most denominations are not as severely in opposition as the Roman Catholics.  In fact, a 
large majority of Protestants are in strong support of ESC research, and confident that it 
will do far more good than harm for the human race (Weiss, 2005). 
 
A Global View on Stem Cells         
 The research allowed within a country is determined by governmental laws and 
determined by officials.  People throughout the world have drastically different views on 
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ESC research, which are not always in accordance with local laws.  In the United States it 
is not uncommon to view protesters outside of facilities which deal with stem cell 
research.  Not only will you often find protestors, but these establishments are usually 
forced to maintain tight security because of the pressure of those opposed to ESC 
research.  On the other hand at the Human Fertilization and Embryology Authority in 
downtown London, there are never protestors or a need for strict security.  Generally, the 
people of Europe are much more open to the idea of ESC research, and the laws of these 
nations (as discussed in our chapter-4) seem to reflect that (Holland, 2005). 
 The peoples of Asian countries appear to have a similar acceptance of ESC 
research as the Europeans.  This region of the world believes strongly in not only the 
future of ESC research to help the ill, but also realizes that a great economic gain could 
be achieved by embracing this research.  In fact, many in Asia argue it is unethical not to 
try to save lives with ES cells.  Singapore is rapidly becoming the stem cell Mecca of the 
world, welcoming the biotechnological community.  The government of Singapore has 
even constructed official and public committees to come together and devise a plan for 
creating ethical guidelines for stem cell research.  Though ESC research is welcome in 
this city, it is not supported by everyone.  A common bumper stick often seen on vehicles 
traveling the streets of Singapore reads, “Embryos- Let them live, you were once an 
embryo too” (Weiss, 2005). 
 In the United States, the public seems to be ethically and morally divided.  As 
mentioned earlier, protesting and rallies denouncing stem cell research are an everyday 
occurrence.  Some opponents of ESC research are in favor of furthering the knowledge of 
adult stem cells, and believe that they may be just as useful as ESC; but without the 
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destruction of embryos.  Others believe that embryos left over from in vitro fertilization 
should be used in ESC research.  Some mothers with “excess” embryos would rather 
donate them to ESC research where they will be useful in helping others.  The alternative 
would be that the embryos were destroyed.  In the United States there are over 400,000 
excess embryos in storage, and of that only three percent will be saved for ESC research, 
the rest will be destroyed.  A mother who donated her excess embryos stated, “If they had 
a heartbeat it would make a big difference, but embryos are bunches of cells and I 
couldn’t throw them down the drain when they could further science” (Holland, 2005). 
 
Ethics of Parthenotes 
 Parthenotes are chemically treated eggs that divide to the blastocyst stage without 
fertilization.  Such embryos can not mature into adults, but can be used to derive ES cell 
lines, so parthenotes are perhaps one way to avoid the ethical pitfalls of deriving ES cells 
from fertilized embryos.  To date, ES cell lines have been derived from monkeys but not 
humans (Cibelli et al, 2002).  If this technology can be adapted to humans, most religions 
would support its use instead of using embryos, so long as the eggs are used to save lives. 
 
Ethics of Therapeutic Cloning 
 Somatic cell nuclear transfer is a form of therapeutic cloning in which a line of 
identical stem cells can be created by isolating the nucleus of an adult patient’s fibroblast 
cell obtained from the skin, and injecting the nucleus into an enucleated egg to eventually 
derive an ES line specific for that patient.  The goal is to create an ES cell line specific 
for that patient to avoid their immunorejection when placed back into the patient.  This 
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topic raises ethical and moral issues in which almost all religions and communities 
worldwide are against.  Therapeutic cloning is not only highly controversial, but also is 
illegal in a large portion of the world (National Research Council, 2003).  This procedure 
of creating stem cells creates upheaval because the cells are cloned, and not created 
naturally.  Ethical issues are also raised for a fear of biological mutations and 
abnormalities that may occur during the cloning process.  Scientists believe that with 
further research much of these concerns will be determined as unreasonable (Weiss, 
2005). 
 ESC research has caused ethical and moral opposition globally.  Though some 
communities may be more accepting than others, government officials and laws hinder 
the further progression of researching therapeutic medicine and stem cells applications.  
Until researchers are allowed to explore the possibilities of ESC in great detail, the true 
practicality of ESC applications will remain unknown. 
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CHAPTER-4:  STEM CELL LEGALITIES 
 
 The purpose of this chapter is to examine current laws relating to stem cell use, 
both in the U.S. and abroad. 
 
Roe v. Wade 
 
 
 U.S. legislature regarding the development and use of stem cells began with a 
very important landmark Supreme Court case, Roe v. Wade.  This case questioned the 
constitutionality of abortion, which in turn questioned the legal status of an embryo, and  
laws regulating the extraction of stem cells.  
“Roe v. Wade, 410 U.S. 113 (1973) was a landmark United States Supreme Court case establishing that most laws against 
abortion violate a constitutional right to privacy, overturning all state laws outlawing or restricting abortion. It is one of the 
most controversial decisions in Supreme Court history”(wikipedia.com, 2005) 
This case settled the argument of whether abortion is legal, and opened the doors 
for stem cell research. 
National Bioethics Advisory Commission (NBAC) 
The real debate about stem cells did not transpire until the Clinton Administration 
(nih.gov, 2005). The National Bioethics Advisory Commission (NBAC) was asked by 
President Clinton to prepare a report on stem cells.  In September of 1999 the report was 
finished and handed over to the Clinton Administration.  The guidelines were published 
in the Federal Registrar on August 23, 2000 (MIT, 2005).  
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The report consisted of thirteen guidelines on the ethical uses of stem cells with 
federally funded research (MIT, 2005), and gave restrictions on the sources of stem cells. 
hES cells and embryonic germ cells (EG cells) were now only to be harvested from 
embryos from in vitro fertility clinics or cadaver fetuses.  ES cells could not be obtained 
by somatic cell nuclear transfer (SCNT) or from embryos created specifically for research 
by means of in vitro fertilization. 
 When President Bush took office, he delayed the revision of this report so his 
incoming administration had time to review its the information.  In his revised report he 
stated that federal funding would be acceptable only if it was used on ES cell lines 
derived previous to the release of his report on August 9, 2001 (stemcells.nih.gov, 2005). 
Also stated was that federal funding would be available if certain requirements were met: 
1) there must have been informed consent of the donors, 2) the embryos must have been created for reproductive purposes and 
in excess of clinical need, 3) there must not have been any financial inducements to the donors, and 4) the embryos must not 
have been created for research purposes. During fiscal year (FY) 2002, the National Institutes of Health (NIH) funded the first 
grants to conduct human embryonic stem cell research, including both new grants and supplements to existing grants. 
(stemcells.nih.gov, 2005)  
National Institute of Health Report     
The National Institute of Health (NIH) also came out with a report regarding the 
use of federal money on stem cells. “…only (regarding) research involving the derivation 
of ES cells from human embryos, but not to research involving the use of ES cells (MIT, 
2005).”  This quote in a January of 1999 NIH report pushes for a federal ban on the 
derivation of new ES cell lines. “NIH through the Department of Health and Human 
Services permits funding for research on embryos that were not derived by NIH-funded 
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scientists, which, as NBAC points out, might solve the legal problems… (MIT, 2005).”  
During the 2002 fiscal year, at the end of the Clinton Administration, 180 million dollars 
was put into stem cell research (ss.ca.gov, 2005).  
107
th
 Congress 
 During the two years of the 107th Congress eight different pieces of stem cell 
legislation were passed in both the House of Representatives and Senate.  Aside from 
legislation that went though Congress, the Senate Sub Committee on Labor, Health and 
Human Services (HHS) held four separate hearings regarding stem cell research.  
The July 18 hearing focused on the release of a comprehensive report prepared by NIH that described the current state of the 
science on stem cells derived from human embryos, fetal tissue, and adult tissue. In addition, several Senators holding pro-life 
views testified in support of stem cell research. The August 1 hearing focused on intellectual property issues and ethical 
issues. The October 31 hearing focused on testimony from the various derivers of the existing stem cell lines. The September 
25 hearing was held to provide the new Director of NIH with an opportunity to update the Subcommittee on the 
implementation of the President's stem cell decision by NIH, and to hear from researchers on their efforts to obtain the eligible 
stem cell lines listed in the NIH Stem Cell Registry. The Senate Health, Education, Labor and Pensions Committee (Senator 
Edward M. Kennedy [D-MA], Chairman) held one hearing on this topic on September 5, 2001. The hearing focused on the 
quality and viability of the existing stem cell lines. The Secretary of HHS, Tommy G. Thompson, testified (stemcells.nih.gov, 
2005) 
 The House of Rep. also held hearings on the topic of stem cells during the 107th 
Congress. The House Government Reform Subcommittee on Criminal Justice, Drug 
Policy and Human Resources had people testify whom, “adopted frozen embryos from in 
vitro clinics (stemcells.nih.gov, 2005).” 
 The first pieces of legislation to go through the 107th Congress were the bills H.R. 
2059 and S. 723. 2059, introduced into the House by Rep. Jim McDermott (D-WA) 
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(stemcells.nih.gov, 2005).  Labeled as the Stem Cell Research Act of 2001, this bill 
amends the Public Health Services Act, allowing hES cell generation and research 
(stemcells.nih.gov, 2005).   Bill number S. 723 was brought to the Senate by Sen. Arlon 
Specter (R-PA) (stemcells.nih.gov, 2005). Truly a bi-partisan effort, the Senate passed 
the bill.  After the bill was passed certain provisions were made to make sure the bill 
served its purpose.  The provisions for all bills are found at stemcells.nih.gov.    
• Notwithstanding any other provision of law, "the Secretary of Health and Human Services (HHS) may only 
conduct, support, or fund research on, or utilizing, human embryos for the purpose of generating embryonic 
stem cells and utilizing stem cells that have been derived from embryos in accordance with this section" 
(Section 489C).  
• The only embryos that may be used for such activities are "those embryos that otherwise would be discarded 
that have been donated from in-vitro fertilization clinics with the written informed consent of the progenitors."  
• The research involved shall not result in the creation of human embryos.  
• The research involved shall not result in the reproductive cloning of a human being.  
• Any person receiving Federal funds would be prohibited from knowingly acquiring or transferring embryos 
for "valuable consideration." Valuable consideration would not include reasonable payments associated with 
transportation, transplantation, processing, preservation, quality control, or storage.  
• The Secretary of HHS would be required to develop guidelines that would "expand on the rules governing 
human embryonic stem cell research to include rules that govern the derivation of stem cells from donated 
embryos under this section."  
 
The Responsible Stem Cell Research Act of 2001 was the next piece of legislature 
to go through congress. S. 1349 was brought into the Senate by Sen. John Ensign (R-NV) 
(stemcells.nih.gov, 2005). This bill was not written to protect private interests of the 
citizens, but rather to ensure that a good supply of stem cells could be readily available to 
researchers and scientists. “… and to require the Secretary of HHS to maintain a stem cell 
donor bank containing stem cells derived from adult tissue, placentas, and umbilical cord 
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blood (stemcells.nih.gov, 2005).”  H.R. 2096 was introduced by Rep. Christopher Smith 
(R-NJ) (stemcells.nih.gov, 2005) with the following provisions: 
• The Secretary of HHS would have been required to establish and maintain by contract a National Stem Cell 
Donor Bank for the purpose of seeking and preserving donations of "qualifying human stem cells" and shall 
make such donated cells available for biomedical research and therapeutic purposes  
• "Qualifying stem cells" were defined as human cells obtained from human placentas, umbilical cord blood, 
organs or tissues of a living or deceased human being who has been born, or organs or tissues of unborn 
human offspring who died of natural causes (such as spontaneous abortion).  
• The bills would have authorized appropriations of $30 million for FY 2002 and such sums as may be 
necessary for each of the FYs 2003 through 2006 for NIH to conduct and support research using qualifying 
human stem cells.  
 
H.R. 2838 could possibly be the most important piece of legislation to go through 
Congress regarding stem cell use.  Brought to the House by Juanita Millender- McDonald 
(D-CA), the New Century Health Advantage Act serves many purposes 
(stemcells.nih.gov, 2005).  Most importantly this bill nullified the Human Embryo 
research Ban that was passed through the Labor, HHS and Education Appropriations Act 
(stemcells.nih.gov, 2005).  This bill also requires that the NIH conduct hES research and 
report all findings and innovations to congress (stemcells.nih.gov, 2005). Provisions: 
• The Director of NIH would have been required to conduct or support research using human pluripotent stem 
cells derived from excess embryos created for purposes of fertility treatment and in excess of clinical need.  
• Section 510 of the FY 2001 Labor, HHS, and Education Appropriations Act, which prohibits certain research 
involving human embryos, would have been repealed.  
 
Rep. McDermott was also responsible for H.R. 2863, the Cell Development 
Research Act of 2001.  This act did not directly affect the research on stem cells, rather it 
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aided in the overseeing of the research“…requiring the establishment of an additional 
Food and Drug Administration (FDA) Advisory Committee to make recommendations on 
the field of cell development, including human embryonic stem cell research and 
therapeutic cloning (stemcells.nih.gov, 2005).”  The 2863 provisions included: 
A Cell Development Advisory Panel would have been created to provide recommendations to the FDA regarding the 
field of cell development, including human embryonic stem cell research and therapeutic cloning. 
 In connection to this bill H.R. 4011, the Science of Stem Cell Research Act was 
also written.  Brought to the house by Rep. Carolyn Maloney (D- NY), this act created a 
panel to review and evaluate the outcome of Bush’s 2001 stem cell report 
(stemcells.nih.gov, 2005).  The 4011 provisions included: 
• A bipartisan commission to be known as the Stem Cell Research Board would have been established in the 
legislative branch.  
• The Board would have been required to conduct research on the effects of the President's August 9 stem cell 
policy, including the progress in advances in curing certain diseases, and all aspects of the NIH funding 
process for both embryonic and adult stem cell research.  
• The Board would have been required to make recommendations to Congress regarding any changes in 
legislation that may be warranted to reduce any inefficiencies in Federal funding of human embryonic stem 
cell research.  
• The Board would have included members appointed by the President, Speaker of the House, 
minority leader of the House, and majority and minority leaders of the Senate. There was no 
specification in the bill that any of the members be individuals with scientific expertise.  
 
108
th
 Congress 
 On February 27, 2003, the first piece of stem cell legislature passed through the 
House of Representatives (stemcells.nih.gov). The Human Cloning Prohibition Act of 
2003 (H.R.534) was written to outlaw both reproductive and therapeutic cloning, as well 
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as to establish a criminal penalty if the laws the bill established were broken 
(stemcells.nih.gov, 2005).  Although cloning and stem cell research are very much 
different there are some strong connections, and in particular ‘the phrase "human 
cloning" was defined to include somatic cell nuclear transfer technology for the purpose 
of deriving stem cells (stemcells.nih.gov).”  While conducting stem cell research, a 
process was discovered that may allow human cells to be extracted and copied.  The 
process of cloning was ethically argued and lawfully prohibited.  
  Soon after H.R. 534 passed, H.R. 801 was introduced by Rep. Jim Greenwood 
(R-Pa) (stemcells.nih.gov, 2005).  Human cloning would still be prohibited by this act, 
but only reproductive cloning,  the bill would allow therapeutic cloning.  The bill was 
recommended to the House Committee on Energy and Commerce.  
 After the cloning and stem cell debate within the 107th congress the discussion on 
the matter took a back seat. “Rather than passing new legislation, most members of 
Congress appeared willing to accept the President's policy and await the results of its 
implementation before determining whether any specific legislative remedies were 
needed (stemcells.nih.gov, 2005).”  The 108th congress does expect to see changes to 
Bush’s policy.  “It is possible, however, that if the 108th Congress considers the Labor, 
HHS, Education, and Related Agencies Appropriations bill this spring, rather than one 
omnibus spending bill, stem cell amendments may be added.  It is also possible that 
members of Congress who have been active on this issue, such as Senator Specter and 
Senator Sam Brownback (R-KS), will introduce legislation to either expand or limit the 
President's policy (stemcells.nih.gov, 2005).”  
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State Laws    
In addition to the national debate on ES cell research, individual states have also 
taken up the debate.  Both the state and federal government have control over the issue of 
stem cells, unless Congress deems it illegal, which is not very likely.  Currently 26 states 
have legislation on the books regarding the regulation of stem cell research 
(bioethics.gov, 2005).  Below is part of an interview by Dr. Lori Andrews a science and 
technology law expert: 
Now, the states as well as the Federal Government have a role in setting policy in this area, and 26 states have laws that 
govern research on fetuses and embryos.  They are enormously different, and they vary widely on things such as 
whether they only apply in situations where there's been an abortion.  For example, 12 of the states only apply if the 
research subject was the subject of a planned abortion.   
So there's more leeway in those states to do research on a miscarried fetus, but there are medical reasons to think that 
might be less than optimal, since most stem cell research will not take place on miscarried conceptuses but on in vitro 
embryos.  
In that situation, we currently have nine states that banned research on IVF embryos altogether.  And what that means, 
though, is that it doesn't really get to the heart of the activity.  For example, if Dr. Gearhart found that a certain type of 
destructive embryo research produced a safe and effective therapy, once it passed the experimental stage it could be 
done in those states.  It only applies when the activity is at the research stage.  
   Some states have bans on the destruction of a human embryo or fetus for any 
purpose, making stem cell research and abortion completely illegal (bioethics.gov, 2005). 
Some states have also started to create advisory boards. Biotechnology companies would 
have to go in front of these boards to explain the purpose of their research.  The panel 
would hold the ability to grant research rights, or to say no.   
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 While some states are creating panels, other states have created a system of 
consent (bioethics.gov, 2005).  In California it is legal to perform all types of stem cell 
research from all sources, but with one stipulation: the researchers must have written and 
documented consent from the donor of the fetus or embryo.  This has raised the question, 
why consent from women is needed, but not men.   California was also the first state to 
float a bond establishing a stem cell research center, with bond money funding research 
in the center.  Other states soon worried about a possible brain drain of stem cell 
scientists to that state, so others soon followed, including New Jersey, then 
Massachusetts.  Likely this trend of states overriding federal stem cell laws will continue. 
 Although much progress has been made in the area of stem cell research law, the 
variation from state to state law needs improvement. Some states do not allow early stage 
research such as Massachusetts, but Connecticut does. A biotechnology company in 
Conn. could do the research and then send the cells to Mass. for clinical study. These 
laws will most likely change with time, as will the ability to derive and regenerate stem 
cells.  With time will come improvements in research, ethics, law and application. 
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CONCLUSIONS 
 
 Stem cell therapies have a promising future which will certainly change the world 
of science and medicine.  ES cells are the only types of cells capable of forming many 
different types of tissues, a property that will benefit mankind greatly in the years to 
come.  Such cells will be used to repair and replace damaged tissue and organs, and also 
will play a vital role in curing many degenerative diseases.  Adult stem cells are already 
currently used in everyday therapeutic procedures, and as time goes on more types of 
these will be discovered.  
 Ethical and moral issues are severely impeding the advancement of ES cell 
research.  With further investigation, the public may realize IVF embryos are already 
routinely being disposed of, so why not allow ES cells to be isolated from them to save 
lives?  Similarly the current legislation in the U.S. is severely impeding the forward 
progress of regenerative medicine.  The authors of this IQP support the trend of states and 
the private sector funding research to override current federal laws.  Our hope is that the 
congress and President design looser guidelines for federal funding of this research, and 
in coordination with less strict state laws allowing research, the United States may retain 
its status at the forefront of the race to commercialize stem cell use. 
 Stem cells represent the future of biotechnology.  The sooner the U.S. drops its 
semi-conservative views the closer we will be to curing Parkinson’s, stopping birth 
defects, eradicating Alzheimer’s, and possibly even growing new body parts. This 
process may take decades, but slow improvements are better than no improvements at all.  
 49 
BIBLIOGRAPHY 
 
 
Brain.  Radio Netherlands Wereldomroep.  April 9, 1999.   
<www.rnw.nl/health/ html/brain.html>  July 25, 2005. 
 
Brain Stem Cells to Cure Diabetes.  BBC News.  April 25, 2005.   
<http://news.bbc.co.uk/2/hi/health/4480875.stm>  May 22, 2005. 
 
Buddhism and Stem Cells.  2005. 
(http://www.philly.com/mld/inquirer/9937355.htm) 
 
Cancer Facts.  National Cancer Institute.  August 31, 2004.  
<http://cis.nci.nih.gov/fact/7_41.htm>  July 20, 2005. 
 
Cibelli JB, Grant KA, Chapman KB, Cunniff K, Worst T, Green H, et al (2002) 
Parthenogenetic Stem Cells in Non-human Primates.  Science  295: 819. 
 
Dabu, Christl.   Stem-cell Science stirs debate in Muslim World, too.  2005. 
http://www.csmonitor.com/2005/0622/p15s02-wogi.html 
 
Eisenberg, Daniel, MD.  Stem Cell Research in Jewish Law.  2001. 
 http://www.jlaw.com/Articles/stemcellres.html 
 
Holland, Jennifer S.  “With more and more countries developing stem cell therapies, the 
United States is in real danger of being left behind.” National Geographic.  July 2005: 9, 
10, 14, 18, 21, 24. 
 
McClean, Phillip.  The Recombinant DNA Debate.  1997.  
http://www.ndsu.nodak.edu/instruct/mcclean/plsc431/debate/debate5.htm 
 
National Research Council.  Stem Cells and the Future of Regenerative Medicine.  
Washington DC:  National Academy Press, 2003.       
 
Potten, C.S.  Stem Cells.  Boston:  Academic Press, 1997. 
 
Researchers Reveal New Prospects for Treating Muscular Dystrophy.  AAAS.  July 10, 
2003.  <www.aaas.org/news/ releases/2003/0710md.shtml> August 1, 2005.   
 
Stem Cells and Diabetes.  National Institute of Health.  August 12, 2005.   
<http://stemcells.nih.gov/info/scireport/chapter7.asp> August 15, 2005. 
 
Tae-gyu, Kim.  Stem Cell and Buddhism.  2005. 
(http://times.hankooki.com/lpage/biz/200505/kt2005052419231011910.htm)   
 
 50 
 
University of Minnesota, Cancer Center (2005) Transplant Biology and Therapy, 
Historical Overview.  http://www.cancer.umn.edu/page/research/trsplant/bmthist.html 
 
Viacell (2005) www.viacellinc.com 
 
Weiss, Rick.  “The Power to Divide:  Stem Cells.”  National Geographic.  July 2005: 3-
7, 15-17. 22-27.   
 
